Speculation on buy out October 17th is the Deadline for Canadian legalization of marijuana. It has raised many questions, including how large the market for cannabis in Canada will be and whether there will be enough product on store shelves. Estimates are from $4 billion to $10 billion in the first few years of implementation.
FSD Pharma (OTCMKTS: FSDDF) (CNSX: HUGE) through its wholly-owned subsidiary FV Pharma, is a licensed producer of marijuana under the Access to Cannabis for Medical Purposes Regulations. Headquartered at the 70-acre former Kraft Heinz Co. (NASDAQ: KHC) plant in Cobourg, Ontario, FV Pharma’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world.
Additionally, they have intelligently secured strategic, highly liquid investments in 6 companies with Incredible Potential ROI, access to their products, customers, and/or profits. With their incredible balance sheet showing No Debt, $31M in Cash, and $51M in assets, this places them in an ideal situation for a major acquisition from the beverage or tobacco industry. FSD Pharma is also actively pursuing opportunities to uplist to NASDAQ.
FSD Pharma (OTCMKTS: FSDDF) (CNSX: HUGE) might be your last chance to get in early in the Canadian Cannabis Sector boom.
Capturing market share early